| LHB |
LHB: Lutropin subunit beta precursor |
BMX |
IPI00514142 |
6.132 |
Evidence |
|
| FSHB |
FSHB: Follitropin subunit beta precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
6.132 |
Evidence |
|
| MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
6.132 |
Evidence |
|
| TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
NME3 |
NME3: Nucleoside diphosphate kinase 3 |
6.127 |
Evidence |
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
OCLN |
OCLN: Occludin |
6.127 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
6.122 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
VIL1 |
VIL1, VIL: Villin-1 |
6.122 |
Evidence |
|
| AURKA |
AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
6.122 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
EIF2AK3 |
EIF2AK3, PEK, PERK: Eukaryotic translation initiation factor 2-alpha kinase 3 pr |
6.12 |
Evidence |
|
| PSMA7 |
PSMA7: Proteasome subunit alpha type-7 |
EIF2AK3 |
EIF2AK3, PEK, PERK: Eukaryotic translation initiation factor 2-alpha kinase 3 pr |
6.12 |
Evidence |
|
| RAC1 |
RAC1, MIG5: Ras-related C3 botulinum toxin substrate 1 precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
6.12 |
Evidence |
|
| COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
6.117 |
Evidence |
|
| EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
6.117 |
Evidence |
|
| ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
6.117 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
6.117 |
Evidence |
|
| CYP2C9 |
CYP2C9, CYP2C10: Cytochrome P450 2C9 |
CYP2C19 |
CYP2C19: Cytochrome P450 2C19 |
6.115 |
Evidence |
|
| CYP2A6 |
CYP2A6, CYP2A3: Cytochrome P450 2A6 |
PKLR |
IPI00334779 |
6.115 |
Evidence |
|
| DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
6.115 |
Evidence |
|
| DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
6.115 |
Evidence |
|
| SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.115 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.115 |
Evidence |
|
| GIT2 |
IPI00238218 |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
6.115 |
Evidence |
|
| NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
KCNIP3 |
KCNIP3, CSEN, DREAM, KCHIP3: Calsenilin |
6.115 |
Evidence |
|
| RAB5B |
RAB5B: Ras-related protein Rab-5B |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
6.115 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
6.115 |
Evidence |
|
- 
-